Thiazolidinediones Inhibit Mouse Osteoblastic MC3T3-E1 Cell Proliferation in Part Through the Wnt Signaling Pathway

被引:3
作者
Duan, Miao [1 ,2 ]
Zhou, Bowen [1 ,3 ]
Zhou, Xinrong [1 ]
Yuan, Gang [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China
[2] Wuhan 1 Hosp, Dept Endocrinol, Wuhan, Peoples R China
[3] Wuhan 6 Hosp, Dept Endocrinol, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
PPAR gamma; Wnt signaling; osteoblasts; cell proliferation; ACTIVATED-RECEPTOR-GAMMA; BONE-MINERAL DENSITY; PPAR-GAMMA; BETA-CATENIN; DIFFERENTIATED OSTEOBLASTS; ROSIGLITAZONE; GENE; EXPRESSION; POLYMORPHISMS; ADIPOGENESIS;
D O I
10.1097/JIM.0000000000000191
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Peroxisome proliferator-activated receptor gamma (PPAR gamma) and Wnt play different roles in bone homeostasis. Thiazolidinediones are PPAR gamma agonists that cause bone mineral density loss. This study investigated the relationship between PPAR gamma and Wnt/beta-catenin signaling in mouse osteoblastic MC3T3-E1 cells. Methods: MC3T3-E1 cells were treated with either pioglitazone (Pio) or rosiglitazone (Rosi), thiazolidinediones, for 24 hours at 10 to 40-mu M concentrations. Recombinant mouse Wnt3a protein (50 ng/mL) for 6 hours was also used to treat the 20-mu M Pio and Rosi pretreated cells. Cell proliferation was measured by MTT, and apoptosis with flow cytometry using annexin V/propidium iodide staining; reverse transcriptase-polymerase chain reaction measured mRNA expression levels of LRP5/6 (low-density lipoprotein-related protein 5/6), glycogen synthase kinase 3 beta (GSK3 beta), TCF7L2 (transcription factor 7-like 2), PPAR gamma, and cyclin D1, and Western blots detected beta-catenin and p-GSK3 beta proteins. Results: Pioglitazone and Rosi decreased MC3T3-E1 cell viability by 28.07% and 18.14% at 20 mu M, respectively (P < 0.05). Apoptosis increased compared with controls (7.21%), after 20-mu M treatment with Pio or Rosi, to 10.45% and 12.10%, respectively (P < 0.05). Both Pio and Rosi decreased beta-catenin protein levels and increased p-GSK3 beta, but the LRP5/6, GSK3 beta, and TCF7L2 mRNA levels were constant. Upon activation of the Wnt pathway by mouse Wnt3a protein, beta-catenin and p-GSK3 beta protein levels were reversed, accompanied with increased proliferation, but apoptosis remained high. Conclusions: Activation of PPAR gamma in osteoblasts accompanied Wnt signaling suppression. Activation of Wnt signaling alleviated the PPAR gamma proliferation decreases but not the apoptosis increases. The thiazolidinedione PPAR gamma agonists act in part through inhibition of the Wnt signaling pathway, showing there is a relationship between PPAR gamma and Wnt signaling.
引用
收藏
页码:758 / 764
页数:7
相关论文
共 48 条
[1]   PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors [J].
Akune, T ;
Ohba, S ;
Kamekura, S ;
Yamaguchi, M ;
Chung, UI ;
Kubota, N ;
Terauchi, Y ;
Harada, Y ;
Azuma, Y ;
Nakamura, K ;
Kadowaki, T ;
Kawaguchi, H .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (06) :846-855
[2]   Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation [J].
Ali, AA ;
Weinstein, RS ;
Stewart, SA ;
Parfitt, AM ;
Manolagas, SC ;
Jilka, RL .
ENDOCRINOLOGY, 2005, 146 (03) :1226-1235
[3]   Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT [J].
Almeida, M ;
Han, L ;
Bellido, T ;
Manolagas, SC ;
Kousteni, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (50) :41342-41351
[4]   Increased Lipid Oxidation Causes Oxidative Stress, Increased Peroxisome Proliferator-activated Receptor-γ Expression, and Diminished Pro-osteogenic Wnt Signaling in the Skeleton [J].
Almeida, Maria ;
Ambrogini, Elena ;
Han, Li ;
Manolagas, Stavros C. ;
Jilka, Robert L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (40) :27438-27448
[5]   Wnt signaling and osteoblastogenesis [J].
Bodine, Peter V. N. ;
Komm, Barry S. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2006, 7 (1-2) :33-39
[6]   The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice [J].
Bodine, PVN ;
Zhao, WG ;
Kharode, YP ;
Bex, FJ ;
Lambert, AJ ;
Goad, MB ;
Gaur, T ;
Stein, GS ;
Lian, JB ;
Komm, BS .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (05) :1222-1237
[7]   PPAR agonists odulate human osteoclast formation and activity in vitro [J].
Chan, B. Y. ;
Gartland, A. ;
Wilson, P. J. M. ;
Buckley, K. A. ;
Dillon, J. P. ;
Fraser, W. D. ;
Gallagher, J. A. .
BONE, 2007, 40 (01) :149-159
[8]   PPARs Integrate the Mammalian Clock and Energy Metabolism [J].
Chen, Lihong ;
Yang, Guangrui .
PPAR RESEARCH, 2014, 2014
[9]   Effects of secreted frizzled-related protein 3 on osteoblasts in vitro [J].
Chung, YS ;
Baylink, DJ ;
Srivastava, AK ;
Amaar, Y ;
Tapia, B ;
Kasukawa, Y ;
Mohan, S .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) :1395-1402
[10]   Cellular mechanisms of bone remodeling [J].
Eriksen, Erik Fink .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2010, 11 (04) :219-227